Your browser doesn't support javascript.
loading
Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression.
Santos-García, D; de Deus Fonticoba, T; Suárez Castro, E; Aneiros Díaz, A; Cores Bartolomé, C; Feal Panceiras, M J; Paz González, J M; Valdés Aymerich, L; García Moreno, J M; Blázquez Estrada, M; Jesús, S; Mir, P; Aguilar, M; Planellas, L L; García Caldentey, J; Caballol, N; Legarda, I; Cabo López, I; López Manzanares, L; Ávila Rivera, M A; Catalán, M J; López Díaz, L M; Borrué, C; Álvarez Sauco, M; Vela, L; Cubo, E; Martínez Castrillo, J C; Sánchez Alonso, P; Alonso Losada, M G; López Ariztegui, N; Gastón, I; Pascual-Sedano, B; Seijo, M; Ruíz Martínez, J; Valero, C; Kurtis, M; González Ardura, J; Prieto Jurczynska, C; Martinez-Martin, P.
Affiliation
  • Santos-García D; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain. Electronic address: diegosangar@yahoo.es.
  • de Deus Fonticoba T; Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.
  • Suárez Castro E; Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.
  • Aneiros Díaz A; Hospital Arquitecto Marcide y Hospital Naval, Complejo Hospitalario Universitario de Ferrol (CHUF), Ferrol, A Coruña, Spain.
  • Cores Bartolomé C; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Feal Panceiras MJ; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Paz González JM; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Valdés Aymerich L; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • García Moreno JM; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Blázquez Estrada M; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Jesús S; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Mir P; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Aguilar M; Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain.
  • Planellas LL; Hospital Clínic de Barcelona, Barcelona, Spain.
  • García Caldentey J; Centro Neurológico Oms 42, Palma de Mallorca, Spain.
  • Caballol N; Consorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain.
  • Legarda I; Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Cabo López I; Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • López Manzanares L; Hospital La Princesa, Madrid, Spain.
  • Ávila Rivera MA; Consorci Sanitari Integral, Hospital General de L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Catalán MJ; Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • López Díaz LM; Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain.
  • Borrué C; Hospital Infanta Sofía, Madrid, Spain.
  • Álvarez Sauco M; Hospital General Universitario de Elche, Elche, Spain.
  • Vela L; Fundación Hospital de Alcorcón, Madrid, Spain.
  • Cubo E; Complejo Asistencial Universitario de Burgos, Burgos, Spain.
  • Martínez Castrillo JC; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Sánchez Alonso P; Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Alonso Losada MG; Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.
  • López Ariztegui N; Complejo Hospitalario de Toledo, Toledo, Spain.
  • Gastón I; Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Pascual-Sedano B; Hospital de Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain.
  • Seijo M; Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • Ruíz Martínez J; Hospital Universitario Donostia, San Sebastián, Spain.
  • Valero C; Hospital Arnau de Vilanova, Valencia, Spain.
  • Kurtis M; Hospital Ruber Internacional, Madrid, Spain.
  • González Ardura J; Hospital Universitario Lucus Augusti (HULA), Lugo, Spain.
  • Prieto Jurczynska C; Hospital Rey Juan Carlos, Madrid, Spain.
  • Martinez-Martin P; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; CIBERNED, Instituto de Salud Carlos III, Madrid. COPPADIS Study Group, Spain.
J Neurol Sci ; 418: 117109, 2020 Nov 15.
Article in En | MEDLINE | ID: mdl-32927370
ABSTRACT

BACKGROUND:

The role of subthreshold depression (subD) in Parkinson's Disease (PD) is not clear. The present study aimed to compare the quality of life (QoL) in PD patients with subD vs patients with no depressive disorder (nonD). Factors related to subD were identified. MATERIAL AND

METHODS:

PD patients and controls recruited from the COPPADIS cohort were included. SubD was defined as Judd criteria. The 39-item Parkinson's disease Questionnaire (PDQ-39) and the EUROHIS-QOL 8-item index (EUROHIS-QOL8) were used to assess QoL.

RESULTS:

The frequency of depressive symptoms was higher in PD patients (n = 694) than in controls (n = 207) (p < 0.0001) major depression, 16.1% vs 7.8%; minor depression, 16.7% vs 7.3%; subD, 17.4% vs 5.8%. Both health-related QoL (PDQ-39; 18.1 ±â€¯12.8 vs 11.6 ±â€¯10; p < 0.0001) and global QoL (EUROHIS-QOL8; 3.7 ±â€¯0.5 vs 4 ±â€¯0.5; p < 0.0001) were significantly worse in subD (n = 120) than nonD (n = 348) PD patients. Non-motor Symptoms Scale (NMSS) total score was higher in subD patients (45.9 ±â€¯32 vs 29.1 ±â€¯25.8;p < 0.0001). Non-motor symptoms burden (NMSS;OR = 1.019;95%CI 1.011-1.028; p < 0.0001), neuropsychiatric symptoms (NPI; OR = 1.091; 95%CI 1.045-1.139; p < 0.0001), impulse control behaviors (QUIP-RS; OR = 1.035; 95%CI 1.007-1063; p = 0.013), quality of sleep (PDSS; OR = 0.991; 95%CI 0.983-0.999; p = 0.042), and fatigue (VAFS-physical; OR = 1.185; 95%CI 1.086-1.293; p < 0.0001; VAFS-mental; OR = 1.164; 95%CI 1.058-1.280; p = 0.0001) were related to subD after adjustment to age, disease duration, daily equivalent levodopa dose, motor status (UPDRS-III), and living alone.

CONCLUSIONS:

SubD is a frequent problem in patients with PD and is more prevalent in these patients than in controls. QoL is worse and non-motor symptoms burden is greater in subD PD patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Quality of Life Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Neurol Sci Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Quality of Life Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Neurol Sci Year: 2020 Document type: Article
...